COVID-19 / Coronavirus

Aramco to expand presence in China by acquiring 10% stake in Rongsheng Petrochemical

2023-03-27 23:10 1756

- Deal involves placement of 480,000 barrels per day of crude to the largest integrated refining and chemicals complex inChina DHAHRAN, Saudi Arabia, March 27, 2023 /PRNewswire/ -- Aramco, one of the world's leading integrated energy and chemicals companies, has signed definitive agreements to ...

CGTN: How China keeps its promise to build a community of common health for mankind

2023-03-27 21:43 1668

BEIJING, March 27, 2023 /PRNewswire/ -- Recognizing China for its support during the pandemic, the Senate of theDominican Republic recently presented China with an award. The Senate's Vice President Santiago Zorrilla said at the award ceremony that theDominican Republic will always remember China...

Aramco JV HAPCO to commence construction of major refinery and petrochemical complex in China

2023-03-27 20:32 1371

* Greenfield project to include 300,000 bpd refinery and 1.65 million tons steam cracker * Aramco to supply up to 210,000 barrels per day of crude oil feedstock to the project * Integrated refining and petrochemical complex expected to be fully operational by 2026 * Complex to be located ...

YS Biopharma's PIKA Recombinant COVID-19 Vaccine Demonstrates Superior Antibody Neutralization Responses Compared to Inactivated COVID-19 Vaccine in Phase II Head-to-Head Clinical Study

2023-03-27 18:00 1213

* The trial met its primary endpoint of superior immunogenicity of PIKA COVID-19 Vaccine vs inactivated COVID-19 vaccine, measured by GMT of neutralizing antibody against Omicron virus on Day 14, with statistical significance (95%CI: 2.1, 3.4, P<0.0001) based on interim data analysis * The tr...

'Generations Connect' Project aims to help boost the well-being of 10,000 elderly

2023-03-24 20:09 1956

HKU medical students to participate in community visits to encourage eHealth literacy improvement of the elderly HONG KONG, March 24, 2023 /PRNewswire/ -- e-Health Literacy is closely related to the health and well-being of the elderly. Sino Group and the Ng Teng Fong Charitable Foundation, in c...

CGTN: How China continues optimizing its COVID-19 response amid other outbreaks

2023-03-24 18:33 2121

BEIJING, March 24, 2023 /PRNewswire/ -- China has entered a new phase of epidemic prevention and control after it downgraded the management of COVID-19 response into Class B infectious diseases. "The overall situation of epidemic response is good nationwide," according to a meeting held by the St...

World TB Day 2023: Illumina and GenoScreen Launch Next Generation Sequencing Innovation to Eliminate Tuberculosis in Africa

2023-03-24 16:07 1295

Transformative Next Generation Sequencing (NGS) Innovation expands access to genomic testing and enables personalized medicine for patients with Tuberculosis (TB) CAPE TOWN, South Africa, March 24, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-bas...

AnPac Bio-Medical Science Granted Continued Listing by NASDAQ Hearing Panel, Subject to Meeting the Equity Rule on or before July 12, 2023

2023-03-23 20:00 2403

NEW YORK, March 23, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations inthe United States andChina focused on early cancer screening and detection and plans to enter into the operation of a business-to-business e-commerce food platf...

Launching an Innovative Product, PlaClin-M, for Safe Environments in the Pandemic Era.

2023-03-23 13:00 1761

SEOUL, South Korea, March 23, 2023 /PRNewswire/ -- CodeSteri, a leading provider of disinfection solutions, is proud to announce the launch of PlaClin-M, a revolutionary device designed to help ensure a clean and safe environment in offices, commercial establishments, and public spaces. CodeSteri...

WuXi Biologics Reports Remarkable 2022 Annual Results

2023-03-22 20:09 2395

Revenue Increased by 48.4% Y-o-Y to RMB15,268.7 Million Gross Profit Increased by 39.2% Y-o-Y to RMB6,724.0 Million Adjusted Net Profit Rose by 47.1% to RMB5,053.9 Million Non-COVID Revenue Achieved 63% Y-o-Y Growth, Strong Momentum Continues into 2023 and Beyond "R" in CRDMO Business Model A...

Kintor Pharma's KX-826 and GT20029 for Treatment of Androgenetic Alopecia (AGA) and Acne Presented at AAD 2023

2023-03-21 15:22 989

SUZHOU, China, March 21, 2023 /PRNewswire/ -- The 2023 Annual Meeting of American Academy of Dermatology Association (AAD 2023) was held from 17 to21 March 2023 in New Orleans, Louisiana, United States. As one of the largest, most influential and representative of all dermatologic associations, ...

Two-Component Recombinant COVID-19 Vaccine ReCOV Granted With Emergency Use Authorization In Mongolia

2023-03-21 13:59 1802

TAIZHOU, China, March 21, 2023 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that in accordance with the Mongolian law on the prevention of novel coronavirus (SARS-CoV-2) outbreak, the Company was granted an...

Aramco and DHL Supply Chain announce new end-to-end Procurement and Logistics Hub joint venture

2023-03-20 21:24 1749

* Plan to provide world-class integrated procurement and supply chain services * First hub of its kind in the region catering to customers in the industrial, energy, chemical and petrochemical sectors * Move expected to help customers drive supply chain efficiency and cost benefits, while red...

Building Back: Helping Young People Go from Recovery to Discovery

2023-03-20 21:00 1378

Outward Bound International releases timely and relevant report about the role of outdoor learning in addressing youth mental health and helping young people build back post pandemic. NEW YORK, March 20, 2023 /PRNewswire/ -- Outward Bound International, the coordinating organization for Outward ...

CNEY Wins a Large Activated Carbon Order

2023-03-20 20:30 1314

LISHUI, China, March 20, 2023 /PRNewswire/ -- CN Energy Group. Inc. (NASDAQ: CNEY) ("CNEY", or the "Company") today announced that its wholly-owned subsidiary, Zhejiang CN Energy New Materials Co., Ltd., has recently signed a contract to supply its high-quality wood-based activated carbon to a bu...

ETANA HAS SECURED FINANCING FROM DEG, EAST VENTURES AND OTHER GLOBAL INVESTORS

2023-03-20 15:22 2122

JAKARTA, Indonesia, March 20, 2023 /PRNewswire/ -- PT Etana Biotechnologies Indonesia (Etana), an Indonesian biopharmaceutical company, has secured a new round of investment led by DEG followed by Yunfeng Capital, HighLight Capital and East Ventures. This round of financing will be used for fu...

YS BIOPHARMA TO RING THE OPENING BELL AND DEBUT ON NASDAQ

2023-03-17 04:30 1908

YS Biopharma Ordinary Shares and Warrants to Trade on the Nasdaq Under Tickers "YS" and "YSBPW" NEW YORK, March 17, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (the "Company" or "YS Biopharma"), a global biopharmaceutical company focusing on new generations of vaccines and therapeutic biologic...

Dynata's new Global Consumer Trends survey: 42% of people optimistic about 2023, despite inflation and higher numbers struggling to make ends meet and reduce debt

2023-03-15 20:03 1641

Data reveals self-reported mental health trending more positively around the world, despite younger generations' financial hardship worsening compared to summer 2022 DALLAS, March 15, 2023 /PRNewswire/ -- Dynata, the world's largest first-party data company for insights, activation and measureme...

YS BIOPHARMA AND SUMMIT HEALTHCARE ANNOUNCE SHAREHOLDER APPROVAL OF BUSINESS COMBINATION

2023-03-15 04:01 3274

* Business Combination to deliver approximately $36 million of gross proceeds * YS Biopharma expects to close the Business Combination on March 16, 2023 * YS Biopharma Ordinary Shares and YS Biopharma Warrants expected to begin trading on the Nasdaq onMarch 17, 2023 under the symbols "YS" and...

Mabwell Launched First in human Clinical Trial of Its Iron Homeostasis Regulating Macromolecular Drug 9MW3011

2023-03-14 23:42 1693

SHANGHAI, March 14, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, launched first in human clinical trial of its iron homeostasis regulating macromolecular drug 9MW3011. The study (CTR20230046) is a phase 1, single cente...

12345678 ... 216